News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genzyme Corporation (GENZ) to Make Third Attempt at FDA Nod for Pompe Disease Drug



1/22/2010 7:45:39 AM

Bookmark and Share

Masshightech.com -- Genzyme Corp. has announced that the U.S. Food and Drug Administration will issue a new decision on its drug for Pompe disease in June. The FDA first rejected the drug in March and then again in November. The second rejection was related to problems with the Allston-based manufacturing plant that produced it. The drug is currently approved in 40 other countries, where it is called Myozyme.

Read at Mass High Tech
Read at Wall Street Journal
Read at Reuters


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES